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July 1, 2016 
 
 
Steven T. James 
House Clerk 
State House Room 145 
Boston, MA 02133 
 
William F. Welch 
Senate Clerk  
State House Room 335 
Boston, MA 02133 
 
 
Dear Mr. Clerk, 
 
Enclosed, please find a status report on the opioid overdose study authorized by Chapter 55 of 
the Acts of 2015 for your review and consideration.  
 
The current opioid epidemic affecting our Commonwealth’s communities has taken a record 
number of lives in each of the last four years. Opioid Use Disorder is a complex chronic disease, 
and the opioid epidemic is a complex and persistent problem that will not be solved through a 
single solution. Due to the severity of this epidemic and the significance of our preliminary 
findings, we found it important to issue this status report in advance of our forthcoming full 
report. Analytic work is ongoing, and much is yet to be learned from this effort, however, what 
we have learned thus far has prompted us to issue this status report to immediately inform our 
collective work with new insight into overdose-related deaths and the relative risks faced by 
different populations.   
 
I would like to acknowledge that this work has required a significant collaborative effort from 
many government agencies. To this end, we are truly grateful to the many partners which have 
assisted DPH in this work so far. This effort highlights government’s ability to work 
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collaboratively towards efficiently solving complex and urgent problems. With the effort of 
legal, technical, and analytical teams across seven agencies (Department of Public Health, 
EOHHS IT, the Office of the Chief Medical Examiner, the Department of Correction, 
MassHealth, the Center for Health Information and Analysis, and MassIT), Massachusetts has 
been able to develop a novel data model that allows for simultaneous analysis of 10 datasets with 
information relevant to opioid deaths. The goodwill of all parties has been a hallmark of this 
ongoing work.  
 
I would also like to express my appreciation for the opportunity this legislation has provided the 
Department of Public Health.  The ability to look as broadly and as deeply at public health data 
has been a unique challenge, but one that has given us a much greater understanding of the 
current opioid epidemic. The analytic approach authorized by Chapter 55 has enabled 
Massachusetts to serve as a national example for the possibilities of public health’s ability to 
leverage data warehousing to respond to pressing policy and health concerns by allowing 
existing data to be used in new and innovative ways to support policy and decision making, and 
to allocate resources more efficiently and effectively. To this end, other states have already 
engaged the Department in discussions about the technical aspects of this project, and I hope that 
this will serve as a model for how complex problems can be tackled in the future. 
 
Let me once again express my appreciation for this opportunity to better understand the root 
causes of the opioid epidemic. I look forward to sharing the results of our full report with you 
shortly. 
 
 
Sincerely, 
 
 
 
Monica Bharel, MD, MPH 
Commissioner 
Department of Public Health 
Assessment of Massachusetts Opioid-
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Opioid-related deaths in 
Massachusetts increased more than 
350% from 2000 to 2015 
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Chapter 55 Provides the Legal Basis for 
Cross-Agency Collaboration to Study the 
Alarming Trends in Opioid-related Deaths 
•Signed into law in August 2015 
•Requires a comprehensive report to the 
Legislature and cross-agency collaboration to 
examine trends in opioid-related deaths and 
address 7 specific questions  
•Specifies major data sets across government 
•Overcomes legal barriers for use of some data 
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Enterprise SAS  or other software 
(Fixed or Cloud-based servers) 
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… additional data … 
… additional machines … 
… additional data … 
Chapter 55 Privacy Shield: Authorized users only, no write access, analysts cannot see data, automatic cell  suppression, 
delete all temporary work files, full auditability of all data operations. 
Chapter 55 Analysis is Conducted via a Secured 
Public Health Data Warehouse to which Only 
Authorized Users Have Access 
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Chapter 55 – Data mapping 
PDMP 
APCD 
Spine 
Death 
Records 
BSAS 
Treatment 
Toxicology 
Summarized 
APCD 
MATRIS 
(ambulance) 
OCME 
Intake 
Town/Zip 
Level Data  
Summarized 
Casemix 
Dept of 
Corrections 
MA Sheriff’s 
Association 
System Attributes 
 
• Data encrypted in transit & at 
rest 
• Limited data sets unlinked at 
rest 
• Simplified structure using 
summarized data  
• Linking and analytics “on the 
fly” 
• No residual files after query 
completed 
• Analysts can’t see data 
• Automatic cell suppression 
• Possible resolution to issues 
related to 42 CFR part 2 
 
Data Sources 
 
DPH 
 
CHIA (MassHealth) 
 
EOPSS 
 
Jails & Prisons 
All Doors Opening 
 
• Significant coordination 
within DPH 
• Financial and technical 
support from MassIT’s Data 
Office 
• CHIA takes on role as linking 
agent  
• Coordination across agencies 
(legal & evaluation) 
• Volunteer analytic support 
from academia and industry 
 
 
Chapter 55 Data Structure 
Births 
(NAS) 
* Note: Houses of Correction data was 
unavailable at the time this status update 
was written. As such, assessment does 
not reflect HOC inmate outcomes. 
* 
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The 7 Questions 
Learning from Recent Opioid Deaths 
Statutory Question Analytic Question Preliminary Findings 
1. Instances of multiple provider 
episodes, meaning a single 
patient having access to opiate 
prescriptions from more than 1 
provider 
Does an abnormally high number 
of prescribing physicians increase 
a patient’s risk of fatal overdose? 
Individuals who obtain prescriptions for 
opioids from more than one prescriber may 
be at greater risk of death. Based on 
observed data, the use of 3 or more 
prescribers within a 3 month period is 
associated with a 7-fold increase in risk of 
fatal opioid overdose. 
2. Instances of poly-substance 
access, meaning a patient having 
simultaneous prescriptions for an 
opiate and a benzodiazepine or 
for an opiate and another drug 
which may enhance the effects or 
the risks of drug abuse or 
overdose 
Does the concurrent use of 
benzodiazepines and opioids 
increase the risk of fatal opioid 
overdose relative to taking 
opioids alone? 
Preliminary findings support the hypothesis 
that increased risk of fatal overdose is 
associated with concurrent use of opioids 
and benzodiazepines. Based on observed 
data, the concurrent use of benzodiazepines 
and opioids is associated with a 4-fold 
increase in risk of fatal opioid overdose. 
Future analysis should include other drugs.   
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Statutory Question Analytic Question Preliminary Findings 
3. The overall opiate prescription 
history of the individuals, 
including whether the individuals 
had access to legal prescriptions 
for opiate drugs at the time of 
their deaths 
Did opioid-related overdose 
decedents have access to legal 
opioids, defined as a prescription 
filled, around time of death? 
There is evidence to support an emerging 
hypothesis that illegally-obtained substances 
are the driving force behind opioid-related 
deaths. At least 2 out of 3 people who died 
of an opioid-related overdose had an opioid 
prescription between 2011 and 2014. But 
only 8.3% of opioid overdose decedents had 
an opioid prescription in the same month as 
their death. Of those who died of an opioid 
overdose with toxicology reports, 
approximately 83% had illegally-obtained or 
likely illegally-obtained substances in their 
system at time of death. 
The 7 Questions 
Learning from Recent Opioid Deaths 
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Statutory Question Analytic Question Preliminary Findings 
4. Whether the individuals had 
previously undergone voluntary 
or involuntary treatment for 
substance addiction or behavioral 
health 
Substance abuse treatment 
history (voluntary and 
involuntary) of Massachusetts 
residents who died of opioid 
overdose. 
Clients who received voluntary treatment 
had better outcomes than clients who 
received involuntary treatment. 
 
Those who received involuntary treatment 
were 2.2 times more likely to die of opioid-
related overdoses and 1.9 times more likely 
to die of any cause compared to those with a 
history of voluntary treatment and no 
history of involuntary treatment. 
 
The majority of patients who received both 
voluntary and involuntary treatment were 
previously known to or diagnosed by the 
health care system (e.g. previous opioid-
related admission, prior mental health 
treatment, reported prior overdose). 
 
The 7 Questions 
Learning from Recent Opioid Deaths 
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Statutory Question Analytic Question Preliminary Findings 
5. Whether the individuals had 
attempted to enter but were 
denied access to treatment for 
substance addiction or behavioral 
health 
Does denial of service lead to an 
increased risk of fatal opioid 
overdose? 
For this study period, denial of service 
information and waitlist data within the 
BSAS treatment system was not reliably 
captured to enable the understanding of the 
connection between denial of service and 
risk of death. Additionally, it should be noted 
that for individuals that would like to access 
treatment, a number of factors can 
complicate their access to care including 
homelessness, unemployment, insurance, 
childcare, criminal involvement, cost, wait 
time, distance to treatment, and other 
barriers. DPH’s Substance Abuse Helpline is 
actively working to enhance efforts to 
increase access to treatment but is not itself 
a gatekeeper for access. 
The 7 Questions 
Learning from Recent Opioid Deaths 
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Statutory Question Analytic Question Preliminary Findings 
6. Whether the individuals 
had received past 
treatment for a substance 
overdose 
Are those who have had a 
non-fatal overdose more 
likely to die from an 
overdose? 
It is assumed that people with substance use disorders 
who have a history of treatment for nonfatal opioid-
related overdoses are at higher risk for eventually dying of 
an opioid-related overdose. Two datasets were used to 
identify nonfatal opioid-related overdoses: the 
Massachusetts Ambulance Trip Record Information 
System (MATRIS) and Acute Case Mix. At least 30% of 
MATRIS data was unreported and only 20% of data from 
MATRIS and Case Mix overlap. At least 9.3% of people 
with a fatal opioid-related overdose had at least 1 prior 
nonfatal overdose event recorded in either Case Mix or 
MATRIS. Due to the quality of the data, this is an 
underestimate. No differences were found by gender. 
However, there was a difference by age. Compared to 
people aged 45+, those aged 27 and under and those 28 
to 34 were nearly twice as likely to have a previous 
overdose event before death. 
 
The 7 Questions 
Learning from Recent Opioid Deaths 
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Statutory Question Analytic Question Preliminary Findings 
7. Whether any individuals 
had been previously 
detained or incarcerated 
and, if so, whether the 
individuals had received 
treatment during the 
detention or incarceration 
Does treatment during 
incarceration reduce 
likelihood of a fatal overdose? 
Under the DOC’s current program and services, there 
does not appear to be a reduction in the likelihood of 
fatal opioid-related overdose for those inmates 
receiving DOC treatment as compared to those not 
known to have received DOC treatment. It should be 
noted that further analysis is needed to determine 
how the risks associated with being incarcerated (with 
or without treatment) impact the risk of overdose. 
The 7 Questions 
Learning from Recent Opioid Deaths 
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• Statute has authorized DPH to use data and partner with other government 
agencies to create a groundbreaking data linkage to perform this study and 
analysis. 
• This study highlights government’s ability to work collaboratively towards 
efficiently solving complex and urgent problems. 
• The analytic approach authorized by Chapter 55 has enabled Massachusetts to 
serve as a national example of how government can leverage data warehousing to 
respond to pressing policy and health concerns. 
 
• DPH appreciates the opportunity provided by this statute and looks forward to 
sharing the results of its full report. 
Conclusion 
